📰 Clinformatics Data Mart Database News
Clinformatics Data Mart Database News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Clinformatics Data Mart Database. Real-time updates on events, politics, business and more.
May 18, 2024
The average number of inappropriate antibiotics prescribed monthly decreased at the start of the COVID-19 pandemic but returned to pre-pandemic levels by late 2021, data show.
March 25, 2024
Proposed national $35 insulin cap would help some patients, researchers say
February 7, 2024
The association between SGLT2i use and kidney stone risk was similar by race and ethnicity, sex, obesity, and history of chronic kidney disease. Use of an SGLT2 inhibitor instead of other classes of glucose-lowering agents is associated with lower kidney stone risk.
February 2, 2024
Adult patients with type 2 diabetes (T2D) who use a sodium-glucose cotransporter 2 inhibitor (SGLT2i) rather than other classes of glucose-lowering agents Use of an SGLT2 inhibitor instead of other classes of glucose-lowering agents is associated with lower kidney stone risk.
February 2, 2024
Use of an SGLT2 inhibitor instead of other classes of glucose-lowering agents is associated with lower kidney stone risk. Use of an SGLT2 inhibitor instead of other classes of glucose-lowering agents is associated with lower kidney stone risk.
January 31, 2024
This analysis compared outcomes among patients who have Duchenne muscular dystrophy (DMD) and commercial insurance or Medicaid, focusing on how these differ between patients in clinical trials and those who receive treatment post approval.
January 30, 2024
Study compared SGLT2 inhibitors with GLP-1 agonists and DPP-4 inhibitors
January 29, 2024
Compared to glucagon-like peptide 1 receptor agonists and dipeptidyl peptidase 4 inhibitors, Use of sodium-glucose cotransporter 2 inhibitors was linked to a decreased risk of nephrolithiasis in patients with type 2 diabetes.
January 25, 2024
A recent study found that use of optimal guideline-directed medical therapies after heart failure with reduced ejection fraction (HFrEF) diagnosis is low overall, but especially among female patients compared with male patients.
December 26, 2023
A recent study found that uptake of disease-modifying therapies (DMTs) has been low among patients with sickle cell disease, suggesting that more interventions that consider individual patient characteristics are needed to improve adoption.